European Society for Radiotherapy and Oncology (ESTRO) shared a post on LinkedIn:
“Explore the evolving landscape of rectal cancer treatment in this ESTRO24 congress report. From early-stage cancer options to the latest Phase III trials, delve into the innovations and challenges influencing the field.”
Read further.
Source: ESTRO/LinkedIn
More posts featuring ESTRO24 on oncodaily.com